Third quarter data from Evaluate show nine biopharma initial public offerings on Western exchanges totaling $2.39bn. Average ...
Barry Chaiken says AI chatbots are eroding guided self-care and that the industry, rather than tech companies, should set ...
The FDA’s cross-agency initiative to build a fit-for-purpose framework would expand reviewer engagement with external experts ...
Phase I/IIa data for the siRNA drug showed it can cross the blood-brain barrier when administered via subcutaneous injection, ...
Iilun Murphy decided to step down as Office of Generic Drugs director for an associate director position, another senior ...
The MedTech Conference, hosted by AdvaMed, will bring more than 4,000 industry leaders to Boston Oct. 18–21 to discuss major ...
With the revised EU pharma directive making antimicrobials prescription-only by default, AESGP and national associations in ...
Thirteen companies received US FDA warning letters between April and September 2026, including BlephEx, Koven Technologies ...
Cosmetics Europe and eight other European brand and manufacturer groups said online marketplaces, social media and ...
AI “dis-intermediates all of the things that we've tried to do to help patients make proper choices, not only with regular ...
The FDA is encouraging lupus drug sponsors to consider enrolling pediatric patients in or alongside their pivotal trials to ...
There are many treatments for inherited retinal dystrophies in development, including products from SparingVision, Atsena and Ocugen. Guidance is needed to address the distinct challenges involved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results